Skip to main content

Bausch & Lomb Corp(BLCO-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low15.67
Day High15.87
Open:15.77
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Tipranks
RBC Capital Reaffirms Their Buy Rating on Bausch + Lomb Corporation (BLCO)
Tipranks
Barclays Reaffirms Their Hold Rating on Bausch + Lomb Corporation (BLCO)
Business Wire
Bausch + Lomb Announces Published Review Examining the Role of B Vitamins in Reducing Risk and Progression of Age-Related Macular Degeneration
Business Wire
Bausch + Lomb Releases 2025 Sustainability Impact Report
Motley Fool
Bausch Lomb BLCO Q2 2025 Earnings Transcript
Motley Fool
Bausch + Lomb (BLCO) Q3 2025 Earnings Transcript
Business Wire
Bausch + Lomb Reports Nearly 725,000 Pounds of Contact Lens, Lens Care and Eye Care Materials Collected and Recycled Through ONE By ONE Recycling Program
StockStory
3 Cash-Burning Stocks We Keep Off Our Radar
BYRN
Tipranks
Bausch + Lomb Wins FDA Clearance for Next-Generation Vitrectomy Cutter and Fluidics Upgrade
Tipranks
Bausch + Lomb Rolls Out enVista Envy Premium Intraocular Lens Across Europe
Tipranks
Citi Reaffirms Their Buy Rating on Bausch + Lomb Corporation (BLCO)
Tipranks
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Bausch + Lomb Corporation (BLCO) and UnitedHealth (UNH)
Business Wire
Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced Update
StockStory
1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off
DHR
Tipranks
Bausch + Lomb to Unveil Broad New Ophthalmic Data at ASCRS Meeting
Business Wire
Bausch + Lomb Launches Preloaded enVista Envy™ Full Range of Vision Intraocular Lenses in Europe
Business Wire
Bausch + Lomb Announces New Scientific Data, Educational Events at the American Society of Cataract and Refractive Surgery Annual Meeting
StockStory
Q4 Rundown: Bausch + Lomb (NYSE:BLCO) Vs Other Medical Devices & Supplies - Specialty Stocks
BLCO
Tipranks
Bausch + Lomb Sets Date for First-Quarter 2026 Results and Investor Call
Business Wire
Bausch + Lomb Will Release First-Quarter 2026 Financial Results on April 29
StockStory
3 Reasons BLCO is Risky and 1 Stock to Buy Instead
BLCO
Tipranks
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Lifecore Biomedical (LFCR), Pyxis Oncology (PYXS) and Bausch + Lomb Corporation (BLCO)
Motley Fool
A Bausch + Lomb Director Just Bought $77,000 in Stock. That's Only Half the Story
Tipranks
Bausch + Lomb’s ELIOS Glaucoma System Hits Key Efficacy Marks in 24‑Month U.S. Trial
Business Wire
Bausch + Lomb Announces Positive 24-Month U.S. Data on the ELIOS™ System for Treatment of Glaucoma
Motley Fool
Billboard Giant Posts $1.6 Billion Revenue as $20.5 Million Bet Makes It a Top Portfolio Holding
Motley Fool
Eye Care Giant Posts $5.1 Billion in Revenue as One Investor Builds Major Position
Tipranks
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Evotec AG (EVO), Shoulder Innovations, Inc. (SI) and Bausch + Lomb Corporation (BLCO)
Tipranks
Bausch + Lomb Launches R&D Webinar Series Spotlighting Glaucoma Pipeline
Business Wire
Bausch + Lomb Launches R&D “Teach-in” Webinar Series
StockStory
Integra LifeSciences, GE HealthCare, Bausch + Lomb, ICU Medical, and Universal Health Services Shares Are Falling, What You Need To Know
IART
Tipranks
Morgan Stanley Sticks to Its Buy Rating for Bausch + Lomb Corporation (BLCO)

Profile

Bausch Lomb Corporation is an eye health company. Its product portfolio includes Biotrue(R) and renu(R) multi-purpose solutions, Biotrue(R) ONEday daily disposable contact lenses, LUMIFY(R) redness reliever eye drops, PreserVision(R) AREDS 2 formula eye vitamin and mineral supplements and VYZULTA(R). Bausch Lomb Corporation is based in VAUGHAN, ON.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.